Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Promoter Methylation in the Genesis of Gastrointestinal Cancer
Yonsei Medical Journal, 07/01/09
Boland CR et al. - This paper reviews the types of genetic alterations that can be found in CRCs and hepatocellular carcinoma (HCC), and focuses upon the epigenetic alterations that result in promoter methylation and the CpG island methylator phenotype (CIMP). The challenge facing CRC research and clinical care at this time is to deal with the heterogeneity and complexity of these genetic and epigenetic alterations, and to use this information to direct rational prevention and treatment strategies.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Retinoic Acid Receptor Antagonists Inhibit miR-10a Expression and Block Metastatic Behavior of Pancreatic Cancer
Gastroenterology, 12/15/09
Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease
World Journal of Gastroenterology, 12/15/09
Role of the receptor for advanced glycation end products in hepatic fibrosis
World Journal of Gastroenterology, 12/15/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09
Complete remission of gastric Burkitt's lymphoma after eradication of Helicobacter pylori
World Journal of Gastroenterology, 12/15/09
Retinoic Acid Receptor Antagonists Inhibit miR-10a Expression and Block Metastatic Behavior of Pancreatic Cancer
Gastroenterology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


